Acute Respiratory Distress Syndrome: Bench-to-Bedside Approaches to Improve Drug Development.
Musaddique Hussain,Chengyun Xu,Mashaal Ahmad,Abdul Majeed,Meiping Lu,Xiling Wu,Lanfang Tang,Ximei Wu
DOI: https://doi.org/10.1002/cpt.1034
2018-01-01
Clinical Pharmacology & Therapeutics
Abstract:Despite 50 years of extensive research, no definite drug is currently available to treat acute respiratory distress syndrome (ARDS), and the supportive therapies remain the mainstay of treatment. To improve drug development for ARDS, researchers need to deeply analyze the omics approaches, reevaluate the suitable therapeutic targets, resolve the problems of inadequate animal modeling, develop the strategies to reduce the heterogeneity, and reconsider new therapeutic and analytical approaches for better designs of clinical trials.